# Tandem Diabetes Care, Inc. (TNDM)

> Tandem Diabetes Care, Inc. (TNDM) trades at $18.62 (-2.26%) as of 11:37:04 AM EST on Nov 5, 2026, +17.77% over the past month. Market cap is $1.33B, with 6.9 days to cover in short interest.

Canonical: https://massive.com/quote/tndm
Data as of: 2026-11-05T16:37:04.529Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$18.62** -0.43 (-2.26%)
As of 11:37:04 AM EST on Nov 5, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Tandem Diabetes Care, Inc. (TNDM) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -2.07% |
| 1W | -5.74% |
| 1M | +17.77% |
| YTD | -15.13% |
| 1Y | +39.95% |
| 52-wk range | $12.26 – $29.65 |

From daily closes through Nov 5, 2026.

## Key statistics

Today's trading snapshot for TNDM: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $18.37 – $19.57 |
| Open | $18.93 |
| Prev close | $19.05 |
| Volume | 457.05K |
| Market cap | $1.33B |
| Shares out | 69.58M |

## Valuation and profitability ratios

Valuation and profitability ratios for Tandem Diabetes Care, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1.18 |
| P/B | 9.42 |
| P/FCF | — |
| ROE | -48.6% |
| ROA | -5.5% |
| Debt/Equity | 4.62 |
| Div yield | 0.00% |

As of Nov 3, 2026

## Insider trading

[Tandem Diabetes Care, Inc. (TNDM) insider trading](https://massive.com/quote/tndm/insider-trading.md): open-market Form 4 buys and sells by Tandem Diabetes Care, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Tandem Diabetes Care, Inc. has disclosed to the SEC on Form 8-K.

- May 21, 2026 · Charter amendment
  “On May 20, 2026, at the 2026 Annual Meeting of Stockholders, the Company's stockholders approved amendments to the Company's Amended and Restated Certificate of Incorporation to: (i) provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law (DGCL); and (ii) among other things, (x) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL and (y) implement certain other changes based on updates to the DGCL.”
- May 15, 2026 · [Executive officer departure](https://massive.com/quote/sec-filings/8-k/executive-departures.md)
  “Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the "Company"), was notified that his employment with the Company is being terminated without cause. Mr. Novara's last day of employment with the Company is scheduled to be May 18, 2026.”
- Feb 27, 2026 · Debt issuance
  “On February 27, 2026, Tandem Diabetes Care, Inc. (the "Company") completed its previously announced private offering (the "Offering") of $300.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the "Notes"), including the exercise in full of the initial purchasers' option to purchase up to an additional $35.0 million principal amount of Notes. The Notes were issued in accordance with an indenture, dated February 27, 2026 (the "Indenture"), between the Company and U.S. Bank Trust Company, National Association, as trustee.”
- Nov 12, 2025 · Director appointment
  “On November 7, 2025, the Board of Directors (the "Board") of Tandem Diabetes Care, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased the size of the Board from eight to nine directors and appointed Sandra Beaver, age 48, to serve as a member of the Board, with a term of office that expires at the Annual Meeting of Stockholders of the Company to be held in 2026. Additionally, the Board appointed Ms. Beaver as a member of the Audit Committee of the Board (the "Audit Committee") and the Cybersecurity and Data Privacy Committee of the Board (the "C/D/P Committee").”
- Aug 7, 2025 · [Regulatory decision](https://massive.com/quote/sec-filings/8-k/regulatory-decisions.md)
  “On August 6, 2025, Tandem Diabetes Care, Inc. (the "Company") received 510(k) clearance from the U.S. Food and Drug Administration for the SteadiSet™ infusion set ("SteadiSet") for up to seven days of use.”

## Dividend history and stock splits

Tandem Diabetes Care, Inc.'s recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-10 · Oct 10, 2017

## TNDM short interest

How heavily TNDM is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 6.9 |
| Short interest | 15.09M |
| Avg volume | 2.2M |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## TNDM news

The latest news and headlines about Tandem Diabetes Care, Inc. (TNDM).

- [Is it the Right Time to Hold TNDM Stock in Your Portfolio?](https://www.zacks.com/stock/news/3003781/is-it-the-right-time-to-hold-tndm-stock-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-3003781) · Zacks Investment Research · Oct 9, 2026 · neutral sentiment
- [Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now](https://www.zacks.com/stock/news/2987312/reasons-to-retain-tandem-diabetes-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2987312) · Zacks Investment Research · Sep 9, 2026 · neutral sentiment
- [Aging Population Drives Healthcare Growth: Stocks to Watch](https://www.zacks.com/stock/news/2982600/aging-population-drives-healthcare-growth-stocks-to-watch?cid=CS-ZC-FT-seniors_&_aging-2982600) · Zacks Investment Research · Aug 31, 2026 · positive sentiment
- [FDA Flags High-Risk Recall For Tandem Diabetes Mobi Pumps](https://www.benzinga.com/news/fda/26/04/52042968/fda-flags-high-risk-recall-for-tandem-diabetes-mobi-pumps?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Apr 24, 2026 · negative sentiment
- [Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm](https://www.globenewswire.com/news-release/2026/03/27/3263782/0/en/Tandem-Diabetes-Care-Inc-Investigated-by-the-Portnoy-Law-Firm.html) · GlobeNewswire Inc. · Mar 27, 2026 · negative sentiment

## About Tandem Diabetes Care, Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 2.5K |
| Listed | Nov 14, 2013 |

[Company website](https://www.tandemdiabetes.com)

## FAQ

### What is the Tandem Diabetes Care, Inc. (TNDM) stock price today?

Tandem Diabetes Care, Inc. (TNDM) is trading at $18.62 (-2.26% on the day) as of 11:37:04 AM EST on Nov 5, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Tandem Diabetes Care, Inc.?

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device.

### What is the short interest in TNDM?

As of Oct 15, 2026, TNDM has 15.09M shares short and 6.9 days to cover.

### What exchange is TNDM listed on?

Tandem Diabetes Care, Inc. (TNDM) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time TNDM quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=TNDM`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Tandem Diabetes Care, Inc. (TNDM) insider trading](https://massive.com/quote/tndm/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
